182 related articles for article (PubMed ID: 31282108)
41. MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response.
Besse A; Sana J; Lakomy R; Kren L; Fadrus P; Smrcka M; Hermanova M; Jancalek R; Reguli S; Lipina R; Svoboda M; Slampa P; Slaby O
Tumour Biol; 2016 Jun; 37(6):7719-27. PubMed ID: 26692101
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
[TBL] [Abstract][Full Text] [Related]
43. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments.
Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4.
Mao K; Lei D; Zhang H; You C
Int J Oncol; 2017 Nov; 51(5):1521-1532. PubMed ID: 29048626
[TBL] [Abstract][Full Text] [Related]
45. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
46. Glioblastoma entities express subtle differences in molecular composition and response to treatment.
Balça-Silva J; Matias D; Do Carmo A; Dubois LG; Gonçalves AC; Girão H; Canedo NHS; Correia AH; De Souza JM; Sarmento-Ribeiro AB; Lopes MC; Moura-Neto V
Oncol Rep; 2017 Sep; 38(3):1341-1352. PubMed ID: 28714013
[TBL] [Abstract][Full Text] [Related]
47. Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Luedi MM; Singh SK; Mosley JC; Hassan ISA; Hatami M; Gumin J; Andereggen L; Sulman EP; Lang FF; Stueber F; Fuller GN; Colen RR; Zinn PO
J Neurosurg; 2018 Dec; 129(6):1446-1455. PubMed ID: 29328002
[TBL] [Abstract][Full Text] [Related]
48. The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells.
Mazor G; Levin L; Picard D; Ahmadov U; Carén H; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Cell Death Dis; 2019 Mar; 10(3):246. PubMed ID: 30867410
[TBL] [Abstract][Full Text] [Related]
49. Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma.
Caragher SP; Shireman JM; Huang M; Miska J; Atashi F; Baisiwala S; Hong Park C; Saathoff MR; Warnke L; Xiao T; Lesniak MS; James CD; Meltzer H; Tryba AK; Ahmed AU
J Neurosci; 2019 Mar; 39(11):1982-1993. PubMed ID: 30651332
[TBL] [Abstract][Full Text] [Related]
50. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
51. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer.
Fatai AA; Gamieldien J
BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978
[TBL] [Abstract][Full Text] [Related]
52. Nestin+/CD31+ cells in the hypoxic perivascular niche regulate glioblastoma chemoresistance by upregulating JAG1 and DLL4.
Zheng ZQ; Chen JT; Zheng MC; Yang LJ; Wang JM; Liu QL; Chen LF; Ye ZC; Lin JM; Lin ZX
Neuro Oncol; 2021 Jun; 23(6):905-919. PubMed ID: 33249476
[TBL] [Abstract][Full Text] [Related]
53. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
[TBL] [Abstract][Full Text] [Related]
54. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
55. Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-β1/Smad signaling pathway.
Jiang Y; Zhou J; Hou D; Luo P; Gao H; Ma Y; Chen YS; Li L; Zou D; Zhang H; Zhang Y; Jing Z
J Pathol; 2019 Sep; 249(1):26-38. PubMed ID: 30953361
[TBL] [Abstract][Full Text] [Related]
56. Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.
Chen Y; Liu P; Sun P; Jiang J; Zhu Y; Dong T; Cui Y; Tian Y; An T; Zhang J; Li Z; Yang X
Theranostics; 2019; 9(5):1453-1473. PubMed ID: 30867843
[TBL] [Abstract][Full Text] [Related]
57. The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
[TBL] [Abstract][Full Text] [Related]
58. SMAGP knockdown inhibits the malignant phenotypes of glioblastoma cells by inactivating the PI3K/Akt pathway.
Ni H; Ji D; Huang Z; Li J
Arch Biochem Biophys; 2020 Nov; 695():108628. PubMed ID: 33049294
[TBL] [Abstract][Full Text] [Related]
59. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
[TBL] [Abstract][Full Text] [Related]
60. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Bacher M; Schrader J; Thompson N; Kuschela K; Gemsa D; Waeber G; Schlegel J
Am J Pathol; 2003 Jan; 162(1):11-7. PubMed ID: 12507885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
